Fluid shear stress induces a shift from glycolytic to amino acid pathway in human trophoblasts.
Fluidic shear stress
Placenta development
Trophoblast metabolism
Journal
Cell & bioscience
ISSN: 2045-3701
Titre abrégé: Cell Biosci
Pays: England
ID NLM: 101561195
Informations de publication
Date de publication:
08 Sep 2023
08 Sep 2023
Historique:
received:
16
01
2023
accepted:
28
08
2023
medline:
9
9
2023
pubmed:
9
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
The human placenta, a tissue with a lifespan limited to the period of pregnancy, is exposed to varying shear rates by maternal blood perfusion depending on the stage of development. In this study, we aimed to investigate the effects of fluidic shear stress on the human trophoblast transcriptome and metabolism. Based on a trophoblast cell line cultured in a fluidic flow system, changes caused by shear stress were analyzed and compared to static conditions. RNA sequencing and bioinformatics analysis revealed an altered transcriptome and enriched gene ontology terms associated with amino acid and mitochondrial metabolism. A decreased GLUT1 expression and reduced glucose uptake, together with downregulated expression of key glycolytic rate-limiting enzymes, hexokinase 2 and phosphofructokinase 1 was observed. Altered mitochondrial ATP levels and mass spectrometry data, suggested a shift in energy production from glycolysis towards mitochondrial oxidative phosphorylation. This shift in energy production could be supported by increased expression of glutamic-oxaloacetic transaminase variants in response to shear stress as well as under low glucose availability or after silencing of GLUT1. The shift towards amino acid metabolic pathways could be supported by significantly altered amino acid levels, like glutamic acid, cysteine and serine. Downregulation of GLUT1 and glycolytic rate-limiting enzymes, with concomitant upregulation of glutamic-oxaloacetic transaminase 2 was confirmed in first trimester placental explants cultured under fluidic flow. In contrast, high fluid shear stress decreased glutamic-oxaloacetic transaminase 2 expression in term placental explants when compared to low flow rates. Placental tissue from pregnancies with intrauterine growth restriction are exposed to high shear rates and showed also decreased glutamic-oxaloacetic transaminase 2, while GLUT1 was unchanged and glycolytic rate-limiting enzymes showed a trend to be upregulated. The results were generated by using qPCR, immunoblots, quantification of immunofluorescent pictures, padlock probe hybridization, mass spectrometry and FRET-based measurement. Our study suggests that onset of uteroplacental blood flow is accompanied by a shift from a predominant glycolytic- to an alternative amino acid converting metabolism in the villous trophoblast. Rheological changes with excessive fluidic shear stress at the placental surface, may disrupt this alternative amino acid pathway in the syncytiotrophoblast and could contribute to intrauterine growth restriction.
Sections du résumé
BACKGROUND
BACKGROUND
The human placenta, a tissue with a lifespan limited to the period of pregnancy, is exposed to varying shear rates by maternal blood perfusion depending on the stage of development. In this study, we aimed to investigate the effects of fluidic shear stress on the human trophoblast transcriptome and metabolism.
RESULTS
RESULTS
Based on a trophoblast cell line cultured in a fluidic flow system, changes caused by shear stress were analyzed and compared to static conditions. RNA sequencing and bioinformatics analysis revealed an altered transcriptome and enriched gene ontology terms associated with amino acid and mitochondrial metabolism. A decreased GLUT1 expression and reduced glucose uptake, together with downregulated expression of key glycolytic rate-limiting enzymes, hexokinase 2 and phosphofructokinase 1 was observed. Altered mitochondrial ATP levels and mass spectrometry data, suggested a shift in energy production from glycolysis towards mitochondrial oxidative phosphorylation. This shift in energy production could be supported by increased expression of glutamic-oxaloacetic transaminase variants in response to shear stress as well as under low glucose availability or after silencing of GLUT1. The shift towards amino acid metabolic pathways could be supported by significantly altered amino acid levels, like glutamic acid, cysteine and serine. Downregulation of GLUT1 and glycolytic rate-limiting enzymes, with concomitant upregulation of glutamic-oxaloacetic transaminase 2 was confirmed in first trimester placental explants cultured under fluidic flow. In contrast, high fluid shear stress decreased glutamic-oxaloacetic transaminase 2 expression in term placental explants when compared to low flow rates. Placental tissue from pregnancies with intrauterine growth restriction are exposed to high shear rates and showed also decreased glutamic-oxaloacetic transaminase 2, while GLUT1 was unchanged and glycolytic rate-limiting enzymes showed a trend to be upregulated. The results were generated by using qPCR, immunoblots, quantification of immunofluorescent pictures, padlock probe hybridization, mass spectrometry and FRET-based measurement.
CONCLUSION
CONCLUSIONS
Our study suggests that onset of uteroplacental blood flow is accompanied by a shift from a predominant glycolytic- to an alternative amino acid converting metabolism in the villous trophoblast. Rheological changes with excessive fluidic shear stress at the placental surface, may disrupt this alternative amino acid pathway in the syncytiotrophoblast and could contribute to intrauterine growth restriction.
Identifiants
pubmed: 37684702
doi: 10.1186/s13578-023-01114-3
pii: 10.1186/s13578-023-01114-3
pmc: PMC10492287
doi:
Types de publication
Journal Article
Langues
eng
Pagination
163Subventions
Organisme : Oesterreichische Nationalbank
ID : 18175
Organisme : Austrian Science Fund
ID : P 33554
Organisme : Austrian Science Fund
ID : I 3304
Organisme : Austrian Science Fund
ID : P 35118
Organisme : Austrian Science Fund
ID : Doc 31-B26
Informations de copyright
© 2023. Society of Chinese Bioscientists in America (SCBA).
Références
Am J Clin Nutr. 2011 Dec;94(6 Suppl):1896S-1902S
pubmed: 21543540
Cell Rep. 2018 Oct 9;25(2):501-512.e3
pubmed: 30304688
Hum Reprod. 2018 Aug 1;33(8):1430-1441
pubmed: 29955830
Biol Open. 2021 Jun 15;10(6):
pubmed: 34100896
Reproduction. 2010 Nov;140(5):759-66
pubmed: 20696850
PLoS One. 2016 Jan 27;11(1):e0147262
pubmed: 26815115
Nucleic Acids Res. 2020 Nov 4;48(19):e112
pubmed: 32990747
J Ultrasound Med. 1996 Feb;15(2):135-42
pubmed: 8622190
Bioinformatics. 2015 Feb 15;31(4):608-9
pubmed: 25677125
Biochim Biophys Acta Mol Basis Dis. 2020 Feb 1;1866(2):165359
pubmed: 30593896
Int J Mol Sci. 2019 Apr 27;20(9):
pubmed: 31035592
Clin Chem. 2018 Mar;64(3):536-546
pubmed: 29301749
Histochem Cell Biol. 2017 Mar;147(3):353-366
pubmed: 27774579
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Int J Mol Sci. 2021 Jul 12;22(14):
pubmed: 34299084
Placenta. 2017 Jun;54:52-58
pubmed: 28117144
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3345-50
pubmed: 18305162
Sci Rep. 2017 Jan 19;7:40771
pubmed: 28102332
Ann Anat. 1996 Dec;178(6):485-501
pubmed: 9010564
Hypertens Pregnancy. 2017 May;36(2):151-160
pubmed: 28609172
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Cancer Lett. 2017 Aug 1;400:37-46
pubmed: 28455244
Nat Protoc. 2013 Feb;8(2):355-72
pubmed: 23348363
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Protoc. 2012 Apr 12;7(5):872-81
pubmed: 22498707
Placenta. 2022 Jul;125:61-67
pubmed: 34920861
PLoS One. 2014 Aug 26;9(8):e106037
pubmed: 25157747
Placenta. 2009 Jun;30(6):473-82
pubmed: 19375795
Dev Cell. 2022 May 23;57(10):1241-1256.e8
pubmed: 35580611
Hum Reprod. 2017 Dec 01;32(12):2382-2393
pubmed: 29136193
Lab Invest. 2016 Apr;96(4):428-38
pubmed: 26752743
Hypertension. 2021 May 5;77(5):1723-1736
pubmed: 33775117
Am J Obstet Gynecol. 2018 Feb;218(2S):S745-S761
pubmed: 29422210
Am J Obstet Gynecol. 2022 Feb;226(2S):S928-S944
pubmed: 33189710
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Curr Vasc Pharmacol. 2021;19(2):113-131
pubmed: 32400334
Lab Chip. 2012 Jun 21;12(12):2165-74
pubmed: 22434367
J Biol Chem. 2003 Jan 10;278(2):703-11
pubmed: 12370194
Cell Mol Life Sci. 2022 Jun 5;79(6):345
pubmed: 35661923
Placenta. 2000 Jan;21(1):14-22
pubmed: 10692246
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):
pubmed: 33402432
Placenta. 2009 Jun;30(6):547-50
pubmed: 19345995
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):19-34
pubmed: 34789002
Mol Cell Biochem. 2020 Nov;474(1-2):15-26
pubmed: 32712749
Metabolites. 2020 Aug 25;10(9):
pubmed: 32854199
Eur J Pharmacol. 2016 Nov 5;790:46-56
pubmed: 27401035
Hum Reprod. 2005 Dec;20(12):3360-8
pubmed: 16123088
Placenta. 2002 May;23(5):392-9
pubmed: 12061855
Int J Mol Sci. 2020 Jun 18;21(12):
pubmed: 32570961
Am J Pathol. 2013 Apr;182(4):1448-58
pubmed: 23410520
Placenta. 2022 Oct;128:116-122
pubmed: 36162142
Nat Commun. 2015 Nov 13;6:8871
pubmed: 26563429
J Clin Endocrinol Metab. 1993 Dec;77(6):1554-62
pubmed: 8263141
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15651-6
pubmed: 19720993
Adv Exp Med Biol. 2017;965:19-44
pubmed: 28132175
Int J Mol Sci. 2020 Jun 30;21(13):
pubmed: 32630006
Mol Pharm. 2022 Nov 7;19(11):3757-3769
pubmed: 36053057
Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1608-1618
pubmed: 31278960